Related Experiment Video
Updated: Apr 18, 2026

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Thermo-sensitive nanoparticles for triggered release of siRNA
Zheng Yang1, Qiang Cheng, Qian Jiang
1a Key Laboratory of Systems Bioengineering of the Ministry of Education, Department of Polymer Science and Technology, School of Chemical Engineering and Technology , Tianjin University , Tianjin 300072 , China.
This study introduces novel thermo-sensitive nanoparticles (DENPs) for efficient cold-shock triggered release of small interfering RNA (siRNA) in cancer gene therapy, demonstrating potent gene silencing and minimal toxicity.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Gene Therapy
Background:
- Efficient delivery of small interfering RNA (siRNA) is critical for cancer gene therapy.
- Thermo-sensitive polymers offer potential for controlled drug release applications.
- Existing siRNA delivery systems face challenges in targeted and triggered release.
Purpose of the Study:
- To develop novel thermo-sensitive nanoparticles (DENPs) for cold-shock triggered siRNA release.
- To evaluate the efficacy and safety of DENPs for cancer gene therapy.
- To investigate the in vivo biodistribution of DENPs.
Main Methods:
- Synthesis of a thermo-sensitive copolymer: poly(ethylene glycol) methyl ether acrylate-b-poly(N-isopropylacrylamide) (mPEG-b-PNIPAM).
- Construction of DENPs using mPEG-b-PNIPAM and a cationic lipid (DC-Chol) via double emulsion-solvent evaporation.
- Characterization of DENPs using transmission electron microscopy and dynamic light scattering.
- Assessment of siRNA encapsulation efficiency and release kinetics under cold-shock conditions.
- In vitro gene silencing efficacy in HeLa-Luc cells and cell viability assays (MTT).
- In vivo biodistribution studies.
Main Results:
- DENPs demonstrated high siRNA encapsulation efficiency (96.8%), significantly reduced without DC-Chol (23.2%).
- Cold shock treatment induced a thermo-sensitive release of siRNA, with approximately 2.2-fold higher cumulative release after 7 days.
- DENPs/siRNA showed potent in vitro gene silencing in HeLa-Luc cells, enhanced by cold shock.
- Cell viability remained above 80% with DENPs/siRNA up to 200 nM, indicating low toxicity.
- In vivo studies showed preferential accumulation of siRNA in the kidney.
Conclusions:
- DENPs represent a novel, cold-shock responsive nanocarrier for efficient siRNA delivery.
- The cold-shock triggered release mechanism offers a new strategy for nanocarrier design.
- This approach holds promise for advancing cancer gene therapy and the delivery of hydrophilic macromolecules.
More Related Videos
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
Translational Regulation
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

